Medical/Pharmaceuticals

WuXi XDC and Boostimmune Sign MOU for Integrated Services

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating ...

2023-08-11 08:30 2377

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating the tumor immune micr...

2023-08-11 08:30 5404

Datasea Launches Innovative "Intelligent Acoustics" Subsidiary in Delaware, Unveiling AI-Integrated Offerings for US Market

BEIJING, Aug. 10, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology corporation engaged in three converging and innovative business segments inChina: intelligent acoustics, 5G messaging, and smart city technology, announced the inception of a who...

2023-08-10 21:30 4862

HitGen Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics

CHENGDU, China, Aug. 10, 2023 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research service agreement with Nested Therapeutics, Inc. ("Nested"), a biotechnology company pioneering a next-generation precisi...

2023-08-10 21:30 3327

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Companies will identify novel therapeutic targets using Standigm's explainable AI and Nashville Biosciences' datasets SEOUL, South Korea, Aug. 10, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discovery and develop...

2023-08-10 21:07 2803

Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- August 10, 2023, in a groundbreaking development, Oricell Therapeutics Co., Ltd. ("Oricell") has received the green light for its Investigational New Drug (IND) application of OriCAR-017, a cutting-edge CAR-T cell therapy targeting GPRC5D to combat relapsed...

2023-08-10 21:00 3953

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...

2023-08-10 20:58 3329

Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation

GUANGZHOU, China, Aug. 10, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced the 510(k) premarket notification submission of the Company's Disposabl...

2023-08-10 19:00 2410

Mediballoon's Online Shop is now live, offering a range of medical balloons and tubing for sale. Mediballoon is your best partner for medical device development.

UNION CITY, Calif., Aug. 9, 2023 /PRNewswire/ -- Mediballoon, Inc., a Medeologix company established in 2016 specializing in medical balloon design, development, and scale-up production, is excited to announce the launch of the Mediballoon Online Shop. This newly unveiled platform caters to engin...

2023-08-09 23:00 2318

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd. (hereinafter referred to as ...

2023-08-09 20:30 4471

Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities

SHENZHEN, China, Aug. 8, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutionsand Operation Smile, a global nonprofit dedicated to transforming the lives of patients and their communities by increasing access to safe surgery and providing high-quality cleft surg...

2023-08-09 11:17 2662

Neuragenex Expands to Open New Illinois Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

CHICAGO, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of four new locations inIllinois. With its groundbreaking approach to chronic pain management that is drug-free and non-in...

2023-08-09 00:14 1712

Neuragenex Expands to Open New Georgia Locations, Giving More People Access to its Innovative Approach to Chronic Pain Management

ATLANTA, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theLawrenceville clinic location in Georgia. With its groundbreaking approach to chronic pain management that is drug-fr...

2023-08-09 00:13 1703

Neuragenex Expands to Open New Utah Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

SALT LAKE CITY, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening ofBluffdale and Lehi clinic locations in Utah. With its groundbreaking approach to chronic pain management that is d...

2023-08-09 00:13 1900

Neuragenex Expands to Open New Texas Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

VICTORIA and WACO, Texas, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theWaco and Victoria clinic locations inTexas. With its groundbreaking approach to chronic pain managem...

2023-08-09 00:03 1832

Vatech Announces Distribution Through Henry Schein to Help Oral Health Professionals Enhance Access to Cutting-Edge Imaging Solutions

HWASEONG, South Korea, Aug. 8, 2023 /PRNewswire/ -- Vatech, a global leader in the dental imaging market, has announced that its products will be distributed byHenry Schein, helping to expand the availability of its cutting-edge products for dental clinics inNorth America. Vatech's portfolio o...

2023-08-08 21:00 3016

I-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023

ROCKVILLE, Md. and SHANGHAI, Aug. 8, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of pioneering immunotherapies, today announced that it will report business and corporate updat...

2023-08-08 20:00 2362

ALPINION Launches a High-Performance Portable Ultrasound Diagnostic Device, X-CUBE i9

SEOUL, South Korea, Aug. 8, 2023 /PRNewswire/ -- ALPINION MEDICAL SYSTEMS Co., Ltd. launched 'X-CUBE i9', a portable ultrasound diagnostic device, with dual batteries and probe connectors that has greatly enhanced the speed and efficiency of examinations.

2023-08-08 17:03 3407

Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 8, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunolo...

2023-08-08 16:10 3596

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors

* Oversubscribed transaction led by Vivo Capital and joined by leading healthcare investors including Adage Capital Partners LP, Exome Asset Management, Janus Henderson Investors, Logos Capital, OrbiMed, Pivotal Life Sciences, RA Capital Management and TCGX * $100 million financing upfront wi...

2023-08-07 23:14 4368
1 ... 175176177178179180181 ... 263